Loading…

Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol

Saved in:

Bibliographic Details
Published in:	International journal of dermatology 2019-06, Vol.58 (6), p.e118-e120
Main Authors:	Aragón‐Miguel, Raquel, Calleja‐Algarra, Alba, Vico‐Alonso, Cristina, Sánchez‐Velázquez, Alba, Garrido, Maria C., Ortiz‐Romero, Pablo L., Rivera‐Díaz, Raquel
Format:	Article
Language:	English
Subjects:	Alopecia Alopecia - chemically induced Alopecia - diagnosis Alopecia - pathology Biological Products - administration & dosage Biological Products - adverse effects Biopsy Certolizumab Pegol - administration & dosage Certolizumab Pegol - adverse effects Drug Substitution Female Humans Immunotherapy Middle Aged Monoclonal antibodies Psoriasis - chemically induced Psoriasis - diagnosis Psoriasis - pathology Sacroiliitis - drug therapy Skin - drug effects Skin - pathology Tumor necrosis factor-α Ustekinumab - administration & dosage
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3
cites	cdi_FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3
container_end_page	e120
container_issue	6
container_start_page	e118
container_title	International journal of dermatology
container_volume	58
creator	Aragón‐Miguel, Raquel Calleja‐Algarra, Alba Vico‐Alonso, Cristina Sánchez‐Velázquez, Alba Garrido, Maria C. Ortiz‐Romero, Pablo L. Rivera‐Díaz, Raquel
description
doi_str_mv	10.1111/ijd.14417
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2216249031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2216249031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3</originalsourceid><addsrcrecordid>eNp1kEtOwzAQQC0EoqWw4AIoEisWaT124sRL1PIpqgSL7i3HH-SS1sFJBGXFETgjJyGQwo7ZjEZ6eiM9hE4Bj6GbiVvpMSQJZHtoCJSlccIo2UdDjAFijlM-QEd1vepOSiA5RAOKc5ICZ0M0e6h9cLJxKpKlr4xy8vP9o3RPJqpkkNq_OiXLKBipGuc3UeMjZULjS_fWrmURVebRl8fowMqyNie7PULL66vl9DZe3N_Mp5eLWFGCs5hJTAjRMjEWSMKYtpKpAhMLjJMiozwDnKsix9righOW5cBtylOcaqJA0xE677VV8M-tqRux8m3YdB8FIcBIwjGFjrroKRV8XQdjRRXcWoatACy-c4kul_jJ1bFnO2NbrI3-I3_7dMCkB15cabb_m8T8btYrvwAFb3Pi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2216249031</pqid></control><display><type>article</type><title>Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Aragón‐Miguel, Raquel ; Calleja‐Algarra, Alba ; Vico‐Alonso, Cristina ; Sánchez‐Velázquez, Alba ; Garrido, Maria C. ; Ortiz‐Romero, Pablo L. ; Rivera‐Díaz, Raquel</creator><creatorcontrib>Aragón‐Miguel, Raquel ; Calleja‐Algarra, Alba ; Vico‐Alonso, Cristina ; Sánchez‐Velázquez, Alba ; Garrido, Maria C. ; Ortiz‐Romero, Pablo L. ; Rivera‐Díaz, Raquel</creatorcontrib><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.14417</identifier><identifier>PMID: 30825196</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Alopecia ; Alopecia - chemically induced ; Alopecia - diagnosis ; Alopecia - pathology ; Biological Products - administration & dosage ; Biological Products - adverse effects ; Biopsy ; Certolizumab Pegol - administration & dosage ; Certolizumab Pegol - adverse effects ; Drug Substitution ; Female ; Humans ; Immunotherapy ; Middle Aged ; Monoclonal antibodies ; Psoriasis - chemically induced ; Psoriasis - diagnosis ; Psoriasis - pathology ; Sacroiliitis - drug therapy ; Skin - drug effects ; Skin - pathology ; Tumor necrosis factor-α ; Ustekinumab - administration & dosage</subject><ispartof>International journal of dermatology, 2019-06, Vol.58 (6), p.e118-e120</ispartof><rights>2019</rights><rights>International Journal of Dermatology © 2019 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3</citedby><cites>FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3</cites><orcidid>0000-0002-2171-7903</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30825196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aragón‐Miguel, Raquel</creatorcontrib><creatorcontrib>Calleja‐Algarra, Alba</creatorcontrib><creatorcontrib>Vico‐Alonso, Cristina</creatorcontrib><creatorcontrib>Sánchez‐Velázquez, Alba</creatorcontrib><creatorcontrib>Garrido, Maria C.</creatorcontrib><creatorcontrib>Ortiz‐Romero, Pablo L.</creatorcontrib><creatorcontrib>Rivera‐Díaz, Raquel</creatorcontrib><title>Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><subject>Alopecia</subject><subject>Alopecia - chemically induced</subject><subject>Alopecia - diagnosis</subject><subject>Alopecia - pathology</subject><subject>Biological Products - administration & dosage</subject><subject>Biological Products - adverse effects</subject><subject>Biopsy</subject><subject>Certolizumab Pegol - administration & dosage</subject><subject>Certolizumab Pegol - adverse effects</subject><subject>Drug Substitution</subject><subject>Female</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Psoriasis - chemically induced</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - pathology</subject><subject>Sacroiliitis - drug therapy</subject><subject>Skin - drug effects</subject><subject>Skin - pathology</subject><subject>Tumor necrosis factor-α</subject><subject>Ustekinumab - administration & dosage</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kEtOwzAQQC0EoqWw4AIoEisWaT124sRL1PIpqgSL7i3HH-SS1sFJBGXFETgjJyGQwo7ZjEZ6eiM9hE4Bj6GbiVvpMSQJZHtoCJSlccIo2UdDjAFijlM-QEd1vepOSiA5RAOKc5ICZ0M0e6h9cLJxKpKlr4xy8vP9o3RPJqpkkNq_OiXLKBipGuc3UeMjZULjS_fWrmURVebRl8fowMqyNie7PULL66vl9DZe3N_Mp5eLWFGCs5hJTAjRMjEWSMKYtpKpAhMLjJMiozwDnKsix9righOW5cBtylOcaqJA0xE677VV8M-tqRux8m3YdB8FIcBIwjGFjrroKRV8XQdjRRXcWoatACy-c4kul_jJ1bFnO2NbrI3-I3_7dMCkB15cabb_m8T8btYrvwAFb3Pi</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Aragón‐Miguel, Raquel</creator><creator>Calleja‐Algarra, Alba</creator><creator>Vico‐Alonso, Cristina</creator><creator>Sánchez‐Velázquez, Alba</creator><creator>Garrido, Maria C.</creator><creator>Ortiz‐Romero, Pablo L.</creator><creator>Rivera‐Díaz, Raquel</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-2171-7903</orcidid></search><sort><creationdate>201906</creationdate><title>Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol</title><author>Aragón‐Miguel, Raquel ; Calleja‐Algarra, Alba ; Vico‐Alonso, Cristina ; Sánchez‐Velázquez, Alba ; Garrido, Maria C. ; Ortiz‐Romero, Pablo L. ; Rivera‐Díaz, Raquel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alopecia</topic><topic>Alopecia - chemically induced</topic><topic>Alopecia - diagnosis</topic><topic>Alopecia - pathology</topic><topic>Biological Products - administration & dosage</topic><topic>Biological Products - adverse effects</topic><topic>Biopsy</topic><topic>Certolizumab Pegol - administration & dosage</topic><topic>Certolizumab Pegol - adverse effects</topic><topic>Drug Substitution</topic><topic>Female</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Psoriasis - chemically induced</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - pathology</topic><topic>Sacroiliitis - drug therapy</topic><topic>Skin - drug effects</topic><topic>Skin - pathology</topic><topic>Tumor necrosis factor-α</topic><topic>Ustekinumab - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aragón‐Miguel, Raquel</creatorcontrib><creatorcontrib>Calleja‐Algarra, Alba</creatorcontrib><creatorcontrib>Vico‐Alonso, Cristina</creatorcontrib><creatorcontrib>Sánchez‐Velázquez, Alba</creatorcontrib><creatorcontrib>Garrido, Maria C.</creatorcontrib><creatorcontrib>Ortiz‐Romero, Pablo L.</creatorcontrib><creatorcontrib>Rivera‐Díaz, Raquel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aragón‐Miguel, Raquel</au><au>Calleja‐Algarra, Alba</au><au>Vico‐Alonso, Cristina</au><au>Sánchez‐Velázquez, Alba</au><au>Garrido, Maria C.</au><au>Ortiz‐Romero, Pablo L.</au><au>Rivera‐Díaz, Raquel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2019-06</date><risdate>2019</risdate><volume>58</volume><issue>6</issue><spage>e118</spage><epage>e120</epage><pages>e118-e120</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>30825196</pmid><doi>10.1111/ijd.14417</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2171-7903</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0011-9059
ispartof	International journal of dermatology, 2019-06, Vol.58 (6), p.e118-e120
issn	0011-9059 1365-4632
language	eng
recordid	cdi_proquest_journals_2216249031
source	Wiley-Blackwell Read & Publish Collection
subjects	Alopecia Alopecia - chemically induced Alopecia - diagnosis Alopecia - pathology Biological Products - administration & dosage Biological Products - adverse effects Biopsy Certolizumab Pegol - administration & dosage Certolizumab Pegol - adverse effects Drug Substitution Female Humans Immunotherapy Middle Aged Monoclonal antibodies Psoriasis - chemically induced Psoriasis - diagnosis Psoriasis - pathology Sacroiliitis - drug therapy Skin - drug effects Skin - pathology Tumor necrosis factor-α Ustekinumab - administration & dosage
title	Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psoriatic%20alopecia%E2%80%90like%20paradoxical%20reaction%20to%20certolizumab%20pegol&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Arag%C3%B3n%E2%80%90Miguel,%20Raquel&rft.date=2019-06&rft.volume=58&rft.issue=6&rft.spage=e118&rft.epage=e120&rft.pages=e118-e120&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.14417&rft_dat=%3Cproquest_cross%3E2216249031%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3207-6a0222da4ef12466dfa6cb02f1692b7397108cb80df0b9267819f59505d2c1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2216249031&rft_id=info:pmid/30825196&rfr_iscdi=true